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Abstract
We examined the association of factors in addition to prehypertensive office blood pressure (BP) 
level that might improve detection of masked hypertension (MH, defined as non-elevated office 
BP with elevated out-of-office BP average) among those otherwise at low-risk. This sample of 340 
untreated adults 30 years and older with office BP average <140/90 mmHg all had two sets of 
paired office BP measurements and 24-hour ambulatory BP monitoring (ABPM) sessions one 
week apart. Other than BP levels, the only factors that were associated (at P<0.10) with MH at 
both sets were male sex (75% vs 66%) and working outside the home (72% vs 59% first set; 71% 
vs 45% second set). Adding these variables to BP level in the model did not appreciably improve 
detection of MH. We found no demographic, clinical, or psychosocial measures that improved 
upon prehypertension as a potential predictor of MH in this sample.
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Introduction
Masked hypertension (MH), defined as non-elevated office blood pressure (BP) with 
elevated average out-of-office BP, conveys cardiovascular risk approaching that of sustained 
hypertension (BP elevated in office and out-of-office).1–5 Studies have demonstrated that 
MH is a reproducible phenotype and that people with BP in the “high-normal” or upper level 
prehypertension range are more likely to have MH.6,7 Detection of MH requires either 
ambulatory BP monitoring (ABPM) or home BP monitoring to acquire data for calculating 
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out-of-office BP average. Given that either method requires resources including equipment 
and time, it would be valuable to have a strategy for targeting which patients with a non-
elevated office BP ought to have systematically performed out-of-office BP measurements in 
order to detect MH.
One could posit reasons why BP might be systematically normal inside the office but 
elevated outside the office. For example, work stress may lead to BP elevations that are 
actually diminished when one is sitting in a health care provider’s office.8 Home strain, trait-
anger, and high stress in general may all act similarly.9–11 Smoking, which transiently raises 
BP, may contribute to an elevated out-of-office BP average that is not detected in a clinical 
setting due to the time refraining from a cigarette.12,13 In one Israeli study, MH was 
associated with younger age, male sex, and higher awake pulse rate.14 Identification of 
factors consistently associated with MH would help clinicians decide which patients with a 
non-elevated office BP should be considered for out-of-office BP monitoring.
We previously reported the sensitivity and specificity of prehypertensive office blood 
pressures for detecting MH.7 In that study, we noted that while an office BP cutoff of 
>120/82 mm Hg had the best performance as a screening test for identifying possible MH, it 
unfortunately had a high false positive rate. A risk assessment that uses variables in addition 
to office BP level might improve prediction and decrease the proportion of people who 
would be tested by ABPM but found to have normal ambulatory blood pressure. In this 
study, we examined the association of several candidate variables with MH and whether any 
associated variables besides prehypertension improved identification of adults with MH who 
were not taking BP lowering medications.
Methods
Study Recruitment and Setting
We recruited 420 adults via a combination of passive recruitment and active recruitment. For 
passive recruitment, we posted signs in seven primary care clinics inviting people with a 
recent office (clinic) BP measurement that was “borderline” or “a little high” to participate. 
Individuals interested in participating contacted a study coordinator to confirm eligibility 
and schedule their study visits. For active recruitment, we sent an email about the study to 
our campus listserv approximately every 3–4 months. Study coordinators also recruited 
potentially eligible participants via electronic medical records review of vital signs 
documented during their most recent primary care clinic visit. To be eligible, a person had to 
be 30 years of age or older, have a primary care clinician, and be on no BP-lowering 
medications. The participant’s most recent clinic visit BP had to be between 120–149 mm 
Hg systolic or 80–95 mm Hg diastolic with neither greater than 149/95 mm Hg. Exclusion 
criteria included diabetes, pregnancy, dementia, any condition that would preclude wearing 
an ambulatory BP monitor, and persistent atrial fibrillation or other arrhythmia. As an 
incentive, participants were offered $150 for completion of the study. All study procedures 
took place in a clinical research center.
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Office Blood Pressure in the Research Setting
At the 4 study visits (Figure 1), following check-in procedures participants were placed in an 
exam room within the clinical research center. After at least a 5-minute rest, same arm BP 
was measured three times by a validated office-type oscillometric device (Welch Allyn Vital 
Signs15) according to recommended timing and positioning and using the appropriate BP 
cuff size.16 The three measurements were averaged to determine the participant’s office BP 
measurement for the visit.
For this analysis, we excluded participants (n=80) with initial research office BP average ≥ 
140/90 mm Hg at the first set of measurements as such participants would either have 
sustained hypertension or white-coat hypertension as opposed to masked hypertension or 
sustained normotension.
Ambulatory Blood Pressure Monitoring
Participants underwent two 24-hour ABPM sessions one week apart using the Oscar 2 
oscillometric monitor (Suntech Medical, Morrisville, NC). The Oscar 2 has been validated 
for use in adults by both the British Hypertension Society protocol and the International 
Protocol for the validation of blood pressure measuring devices.17,18 The monitors were 
programmed to measure BP at 30 minute intervals from 6am to 11pm and at 1 hour intervals 
from 11pm to 6am. The relaxed intervals were chosen to minimize wearer burden given that 
we asked participants to wear the BP monitor twice in a short time span. Maximum BP 
measurement time was limited to less than 140 seconds, and the monitors were set for a 
maximum pressure of 220 mm Hg. Participants were given verbal instructions on wearing 
the monitor, including that that they should try to leave the cuff on during the entire 
monitoring period, that they should try to hold their cuffed arm as still as possible during a 
measurement to ensure that the monitor would get an accurate reading, that cuff inflation 
would cause a tight feeling around the arm, and that faulty readings would trigger a repeat 
measurement. The minimum number of readings we accepted as an adequate ABPM session 
was 14 for daytime and 6 for nighttime.
Other Variables
Perceived stress was measured using the Perceived Stress Scale.19 Trait anger, trait anxiety, 
and state anxiety were measured using the Spielberger inventories.20,21 Job strain was 
measured using the Karasek Job 22, and home life stress was measured using the Home Life 
Pressure Index.23 Height and weight were measured at the first study visit and used to 
calculate body mass index (BMI). Arm circumference at mid-biceps was measured at the 
first study visit and used to guide BP cuff size. Demographics and medical history items 
were collected by self-administered questionnaire.
Analysis
MH was defined as a preceding research office BP average < 140/90 mm Hg with either a 
mean 24-hour ambulatory systolic BP ≥ 130 mm Hg or mean 24-hour diastolic BP ≥ 80 mm 
Hg.24 Normotension was defined as a preceding research office BP average < 140/90 mm 
Hg with both a mean 24-hour ambulatory systolic BP < 130 mm Hg and mean 24-hour 
diastolic BP < 80 mm Hg. We examined bivariate associations of several preselected 
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candidate “predictor” variables with MH separately for each session of paired office and 
ambulatory BP measurements. We modeled the MH status at the two time points 
simultaneously using generalized estimating equations (GEE) method with an exchangeable 
working matrix to account for dependence between two outcomes. The time factor was not 
significant in any of the 3 models and hence was dropped from the final models. Using C-
statistics with MH based on the first set of measurements as the outcome, we compared a 
model containing only BP levels to a model containing other variables that were associated 
with MH at the P<0.10 level at both sessions.
Study Approval
This study was approved by the Office of Human Research Ethics at the University of North 
Carolina at Chapel Hill.
Results
Participant Characteristics
The mean ± standard deviation (±SD) age of the 340 participants included in the analysis 
was 48 (±12) years. Most participants were between 30 and 44 years (44%) or between 45 
and 64 years (44%) (Table 1). A small proportion was older than 65 years (12%). Nearly 
60% were female. Three-fourth were white, and 22% were Black. Most were college 
graduates (64%), and the majority (94%) reported good to excellent health. Most (93%) 
were also nonsmokers and overweight (32%) or obese (39%). The majority were married or 
living with a partner. Only 3 participants did not have sufficient daytime ambulatory BP 
monitor readings at the first session, and 5 did not have sufficient daytime ambulatory BP 
monitor readings at the second session.
Prevalence of Masked Hypertension in the Study Sample
As previously described, the prevalence of MH in the overall study sample was high.25 This 
high prevalence may have been the result of our method of recruiting people who had a 
recent “borderline” office BP measurement. When the sample was restricted to only those 
with prehypertensive research office visit BP average, the prevalence was especially high. 
Using the office BP average paired with the immediately following ABPM average, the 
prevalence of MH based on the first sets of measurements was 69.4% (95% CI 64.1%–
74.7%), and the prevalence based on the second sets of measurements was 65.9% (95% CI 
60.5%–71.3%).
Associations with Masked Hypertension
Other than the BP levels, the only factors that were associated (at P<0.10) with MH at both 
time periods were male sex and working outside the home (Table 2). Using the first set of 
measurements, 75% of men vs 66% of women had MH, and using the second set, 73% of 
men vs 61% of women had MH. Among those who worked outside the home, 72% and 71% 
had MH by first and second set of measurements vs 59% and 45% among those who did not 
work outside the home. None of the candidate psychosocial measures we examined 
appeared to be associated with MH (Table 3). Adding variables to BP level in the model did 
not appreciably improve detection of MH (Table 4).
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Discussion
In this study, we sought to identify factors consistently associated with MH. Identification of 
such factors would help clinicians decide which patients with a prehypertensive office BP 
should be considered for out-of-office BP monitoring in order to detect masked 
hypertension. We examined several candidate demographic, clinical, and psychosocial 
variables, but none was strongly associated with MH. The best “predictor” of MH is 
prehypertensive office BP level.
Other investigators have identified some factors associated with MH. Male sex, high pulse 
rate and smoking were associated with MH in one Israeli study.14 We did not note high pulse 
rate or smoking to be associated with MH, but our study had a low prevalence of smokers, 
and our participants also differed in that they were not actually being seen for a clinical visit 
We did observe male sex to be associated, but it was not helpful in improving detection of 
MH. A different study, conducted in Finland, found older age, higher BMI, smoking, and 
excessive alcohol consumption to be associated with MH.26 Our study did not replicate these 
findings, but we note that the Finnish study was of a much larger sample size (N=1459), 
which increased its power to find statistically significant associations. A prior study, also 
with a much larger sample size, also found job strain (high demand and high decision 
latitude) to be associated with MH in a sample of male white-collar workers, but not among 
female white-collar workers.27
In our study, we noted that simply working outside the home was associated with MH. It is 
important to acknowledge that guidelines recommend that ABPM be performed on a 
workday. In previous work, we pointed out that home BP monitoring and ABPM are not 
interchangeable for detecting MH. The obvious limitation is that home BP measurements are 
typically only made in the morning and in the evening, periods that may miss times when 
BP is prone to elevation. It is possible that a home BP monitor taken to work and used in the 
workplace, or used mid-day at home, might be able to identify MH. Such a protocol could 
be tested in further studies.
Prehypertension increases cardiovascular risk compared to optimal BP, but not enough to 
justify antihypertensive therapy for most patients. It is possible that much of the risk 
attributable to office prehypertension is actually a reflection of a population in which a large 
proportion of people have masked hypertension. We know from multiple studies that the 
cardiovascular risk of MH approaches that of sustained hypertension. Thus, ambulatory BP 
monitoring may be useful to risk stratify patients who have prehypertensive office BPs, for 
whom treatment beyond lifestyle modifications might be considered. It was our hope that 
additional variables could be used to guide such a strategy, but the BP level itself may indeed 
be the best clinical harbinger of potential MH. Further studies are still needed to determine 
whether treatment of MH, guided by out-of-office BP measurements, leads to reduced CVD 
events. The answer may also depend on the natural history of MH, or the time it takes for 
such patients to “transition” to sustained hypertension. Patients’ acceptance of treatment of 
MH—when their office BP is “normal” —also needs to be examined.
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Streamlining use of ABPM to identify MH is desired because of the costs and the potential 
discomfort involved. For patients whose office BP is elevated (i.e. ≥ 140/90 mmHg), 
ambulatory BP monitoring has been shown to be cost-effective compared to reliance of 
office BP measurements alone because of its ability to identify white-coat hypertension, 
which most evidence suggests need not be treated.28 Future analyses could also examine the 
cost of using ambulatory BP monitoring among patients whose BP is prehypertensive. 
Assuming treatment of MH reduces the risk of CVD events, such a strategy might be cost-
effective compared to relying only on office BP measurements and not treating patients with 
MH.
Strengths and Limitations
Strengths of our study included its repeated sets of measurements of office and ambulatory 
BP as well as its measurement of several candidate factors. We also acknowledge several 
limitations. Our sample may not be representative of a general clinic population, and we did 
not include diabetics. The sample also had a high prevalence of MH, which may have 
diminished our ability to identify associated factors. Our sample also had relatively low 
prevalence of risk factors, such as smoking, that have been found in other studies to be 
associated with MH. Finally, there may be factors that are associated with MH that we 
simply did not measure.
Conclusion
Prehypertensive BP levels are associated with MH. The additional factors examined in this 
study did not significantly improve ability to discriminate between people more vs less 
likely to have MH. For now, clinicians and researchers interested in using ambulatory BP 
monitoring to detect MH could consider offering it to patients 30 years and older whose BP 
is in the prehypertensive range.
Acknowledgments
This study was supported by grant R01 HL098604 from the National Heart Lung and Blood Institute.
References
1. Liu JE, Roman MJ, Pini R, Schwartz JE, Pickering TG, Devereux RB. Cardiac and arterial target 
organ damage in adults with elevated ambulatory and normal office blood pressure. Ann Intern 
Med. 1999; 131(8):564–572. [PubMed: 10523216] 
2. Sega R, Trocino G, Lanzarotti A, Carugo S, Cesana G, Schiavina R, Valagussa F, Bombelli M, 
Giannattasio C, Zanchetti A, Mancia G. Alterations of cardiac structure in patients with isolated 
office, ambulatory, or home hypertension: Data from the general population (Pressione Arteriose 
Monitorate E Loro Associazioni [PAMELA] Study). Circulation. 2001; 104(12):1385–1392. 
[PubMed: 11560854] 
3. Fagard RH, Cornelissen VA. Incidence of cardiovascular events in white-coat, masked and sustained 
hypertension versus true normotension: a meta-analysis. J Hypertens. 2007; 25:2193–2198. 
[PubMed: 17921809] 
4. Verberk WJ, Kessesl AG, de Leeuw PW. Prevalence, causes, and consequences of masked 
hypertension: a meta-analysis. Am J Hypertens. 2008; 21:969–975. [PubMed: 18583985] 
Viera et al. Page 6
J Clin Hypertens (Greenwich). Author manuscript; available in PMC 2017 August 01.
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
5. Pierdomenico SD, Pannarle G, Rabbia F, Lapenna D, Licitra R, Zito M, Campanella M, Gaudio C, 
Veglio F, Cuccurullo F. Prognostic relevance of masked hypertension in subjects with 
prehypertension. Am J Hypertens. 2008; 21:879–883. [PubMed: 18464744] 
6. Shimbo D, Newman JD, Schwartz J. Masked hypertension and prehypertension: diagnostic overlap 
and interrelationships with left ventricular mass: the masked hypertension study. Am J Hypertens. 
2012; 25:664–71. [PubMed: 22378035] 
7. Viera AJ, Lin FC, Tuttle LA, Shimbo D, Diaz KM, Olsson E, Stankevitz K, Hinderliter AL. Levels 
of office blood pressure and their operating characteristics for detecting masked hypertension based 
on ambulatory blood pressure monitoring. Am J Hypertens. 2015 Jan; 28(1):42–9. [PubMed: 
24898379] 
8. Lindquist TL, Beilin LJ, Knuiman MW. Influence of lifestyle, coping, and job stress on blood 
pressure in men and women. Hypertension. 1997 Jan; 29(1Pt1):1–7. [PubMed: 9039072] 
9. Suls J, Wan CK, Costa PT Jr. Relationship of trait anger to resting blood pressure: a meta-analysis. 
Health Psychol. 1995; 14(5):444–56. [PubMed: 7498116] 
10. Schum JL, Jorgensen RS, Verhaeghen P, Sauro M, Thibodeau R. Trait anger, anger expression, and 
ambulatory blood pressure: a meta-analytic review. J Behav Med. 2003; 26(5):395–415. [PubMed: 
14593850] 
11. James GD, Yee LS, Harshfield GA, Blank SG, Pickering TG. The influence of happiness, anger, 
and anxiety on the blood pressure of borderline hypertensives. Psychosom Med. 1986; 48:502–8. 
[PubMed: 3763789] 
12. Omvik P. How smoking affects blood pressure. Blood Pressure. 1996; 5:71–77. [PubMed: 
9162447] 
13. Mann SJ, James GD, Wang RS, Pickering TG. Elevation of ambulatory systolic blood pressure in 
hypertensive smokers. A case-control study. JAMA. 1991; 265:2226–2228. [PubMed: 2013955] 
14. Ben-Dov IZ, Ben-Arie L, Mekler J, Bursztyn M. In clinical practice, masked hypertension is as 
common as isolated clinic hypertension: predominance of younger men. Am J Hypertens. 2005; 
18(5 Pt 1):589–593. [PubMed: 15882539] 
15. Jones CR, Taylor K, Poston L, Shennan AH. Validation of the Welch Allyn ‘Vital Signs’ 
oscillometric blood pressure monitor. J Hum Hypertens. 2001; 15:191–195. [PubMed: 11317204] 
16. Pickering TG, Hall JE, Appel LJ, Falkner BE, Graves J, Hill MN, et al. Subcommittee of 
Professional and Public Education of the American Heart Association Council on High Blood 
Pressure Research. Recommendations for blood pressure measurement in humans and 
experimental animals. Part 1: blood pressure measurement in humans. Hypertension. 2005; 
45:142–61. [PubMed: 15611362] 
17. Jones SC, Bilous M, Winship S, Finn P, Goodwin J. Validation of the Oscar 2 oscillometric 24-
hour ambulatory blood pressure monitor according to the International Protocol for the validation 
of blood pressure measuring devices. Blood Press Monit. 2004; 9:219–223. [PubMed: 15311149] 
18. Goodwin J, Bilous M, Winship S, Finn P, Jones SC. Validation of the Oscar 2 oscillometric 24-
hour ambulatory blood pressure monitor according to British Hypertension Society protocol. 
Blood Press Monit. 2007; 12:113–117. [PubMed: 17353655] 
19. Cohen S, Kamarck T, Mermelstein R. A global measure of perceived stress. J Health Soc Behav. 
1983; 24(4):385–396. [PubMed: 6668417] 
20. Spielberger, CD.; Jacobs, G.; Russel, S.; Crane, R. Assessment of anger: the State-Trait Anger 
Scale. In: Butcher, JN.; Spielberger, CD., editors. Advances in Personality Assessment. Vol. 2. 
Hillsdale, NJ: Lawrence Erlbaum Associates; 1983. p. 161-189.
21. Spielberger, CD. Manual for the State-Trait Anxiety Inventory: STAI (Form Y). Palo Alto, CA: 
Consulting Psychologists Press; 1983. 
22. Karasek, R. Job Content Questionnaire and user’s guide. Lowell, MA: University of 
Massachussetts; 1985. 
23. Grewen KM, Girdler SS, Light KC. Relationship quality: effects on ambulatory blood pressure and 
negative affect in a biracial sample of men and women. Blood Press Monit. 2005; 10(3):117–124. 
[PubMed: 15923812] 
24. O’Brien E, Parati G, Stergiou G. Ambulatory blood pressure measurement: what is the 
international consensus? Hypertension. 2013; 62:00–00.
Viera et al. Page 7
J Clin Hypertens (Greenwich). Author manuscript; available in PMC 2017 August 01.
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
25. Viera AJ, Lin FC, Tuttle LA, Olsson E, Stankevitz K, Girdler SS, Klein JL, Hinderliter AL. 
Reproducibility of masked hypertension among adults 30 years or older. Blood Press Monit. 2014 
Aug; 19(4):208–15. [PubMed: 24842491] 
26. Hänninen MR, Niiranen TJ, Puukka PJ, Mattila AK, Jula AM. Determinants of masked 
hypertension in the general population: the Finn-Home study. J Hypertens. 2011 Oct; 29(10):
1880–8. [PubMed: 21841499] 
27. Trudel X, Brisson C, Milot A. Job strain and masked hypertension. Psychosom Med. 2010 Oct; 
72(8):786–93. [PubMed: 20639388] 
28. Lovibond K, Jowett S, Barton P, Caulfield M, Heneghan C, Hobbs FD, Hodgkinson J, Mant J, 
Martin U, Williams B, Wonderling D, McManus RJ. Cost-effectiveness of options for the 
diagnosis of high blood pressure in primary care: a modelling study. Lancet. 2011; 378(9798):
1219–30. [PubMed: 21868086] 
Viera et al. Page 8
J Clin Hypertens (Greenwich). Author manuscript; available in PMC 2017 August 01.
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
Figure 1. 
Participant Study Flow
Viera et al. Page 9
J Clin Hypertens (Greenwich). Author manuscript; available in PMC 2017 August 01.
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
Viera et al. Page 10
Table 1
Participant Characteristics (N=340)
Characteristic n Percent
Age group (years)
 30–44 151 44
 45–64 149 44
 >65 40 12
Female sex 199 59
Race
 Black 74 22
 White 254 75
 Other 12 3
Education level
 Some high school 5 1
 High school graduate 16 5
 Some college 64 19
 College graduate 255 75
Work outside home 263 77
Total household income (annual)
 <$25,000 42 13
 $25,000–50,000 68 20
 >$50,000 226 67
Insurance status
 Private 239 71
 Public 45 13
 Both 33 10
 Uninsured 21 6
Self-reported health
 Excellent/very good 231 68
 Good 90 26
 Fair or poor 19 6
Nonsmoker 315 93
Drink alcohol 125 56
Caffeine intake > 75th percent 81 24
Married or living with partner 217 64
BMI
 Normal (<25 kg/m2) 99 29
 Overweight (25–29 kg/m2) 109 32
 Obese (≥ 30 kg/m2) 132 39
Resting pulse <75 bpm 233 69
Microalbuminuria 76 23
Office systolic BP at visit 1
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Viera et al. Page 11
Characteristic n Percent
 < 120 mmHg 94 31
 120–130 mm Hg 125 41
 131–139 mm Hg 87 28
Office diastolic BP at visit 1
 <80 mmHg 178 56
 80–84 mm Hg 62 20
 85–89 mm Hg 77 24
BMI, body mass index
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